Effects of simvastatin combined with clopidogrel on hs-CRP and blood lipids in patients with acute coronary syndrome
Shao-Wei Chen
Abstract
Shao-Wei Chen
Abstract
Objective:To investigate the effects of simvastatin combined with clopidogrel on high sensitivity C-reactive protein(hs-CRP) and blood lipids in patients with acute coronary syndrome(ACS).Methods:A total of 117 patients with ACS were divided into two groups: simvastatin group(48 patients) and simvastatin combined with clopidogrel group(69 patients).The levels of hs-CRP and blood lipids were detected before and six-week after treatment.Results:The hs-CRP and blood lipids levels of patients significantly decreased in two groups(P0.01 all).Compared with simvastatin group,the hs-CRP levels significantly decreased(P0.05),but the blood lipids levels had not significant decreased(P0.05)in simvastatin combined with clopidogrel group.Conclusion:Treatment with simvastatin combination with clopidogrel not only decrease the blood lipids levels but also has the best effects on lowering hs-CRP.It suggest that it may inhibit inflammatory responses,increase atherosclerotic plaque stabilization in ACS patients.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To investigate the effects of simvastatin combined with clopidogrel on high sensitivity C-reactive protein(hs-CRP) and blood lipids in patients with acute coronary syndrome(ACS).Methods:A total of 117 patients with ACS were divided into two groups: simvastatin group(48 patients) and simvastatin combined with clopidogrel group(69 patients).The levels of hs-CRP and blood lipids were detected before and six-week after treatment.Results:The hs-CRP and blood lipids levels of patients significantly decreased in two groups(P0.01 all).Compared with simvastatin group,the hs-CRP levels significantly decreased(P0.05),but the blood lipids levels had not significant decreased(P0.05)in simvastatin combined with clopidogrel group.Conclusion:Treatment with simvastatin combination with clopidogrel not only decrease the blood lipids levels but also has the best effects on lowering hs-CRP.It suggest that it may inhibit inflammatory responses,increase atherosclerotic plaque stabilization in ACS patients.
Key concepts: Simvastatin, Medicine, Clopidogrel, Acute coronary syndrome, Blood lipids, Internal medicine, C-reactive protein, Aspirin